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Background & objectives : Major histocompatibility complex (MHC) genes are known to influence the immune
functions. In the present study, the influence of non-MHC genes such as mannose binding protein (MBP),
vitamin D receptor (VDR) and interleukin-1 receptor antagonist (IL-IRA) gene polymorphisms on lymphocyte
response to Mycobacterium tuberculosis culture filtrate antigen (10 µg/ml) was studied in 44 patients with active
pulmonary TB and the family contacts (35) and in 32 normal healthy subjects. The influence of these gene
polymorphisms on tuberculin (1TU of PPD of M. tuberculosis) reactivity status in 146 pulmonary TB patients
was also studied.
Methods : The MBP and VDR genes were amplified using polymerase chain reaction (PCR) and genotyping was
carried out using sequence specific oligonucleotide probes by dot blot and IL-1RA by agarose gel
electrophoresis.
Results : A significantly decreased lymphocyte response to M. tuberculosis antigen was seen in pulmonary TB
patients positive for functional mutant homozygotes of MBP (00) compared to heterozygote carriers
(AO; P<0.02) and wild homozygotes (AA; P<0.01). The variant mutant genotype (tt) of VDR gene was
associated with an increased lymphocyte response in control subjects compared to active TB patients with tt
genotype (P<0.05). Heterozygote carriers of MBP (AO) were associated with a significantly (P<0.001) decreased
tuberculin reactivity compared to wild homozygotes (AA). The VDR genotype Tt (heterozygote carrier) was
associated with an increased tuberculin reactivity in female TB patients as compared to male patients (P<0.001).
Interpretation & conclusions : The present study suggested that MBP and VDR genes influence the cell mediated
immune response in pulmonary TB patients. Non-MHC genes along with HLA-Class II genes/gene products
m a y  b e  p l a y i n g  a n  i m m u n o r e g u l a t o r y  r o l e  i n  t h e  m e c h a n i s m  o f  s u s c e p t i b i l i t y / r e s i s t a n c e  t o
tuberculosis.
Key words Gene polymorphisms - IL- 1RA - lymphocyte response - MBP - Mycobacterium tuberculosis - pulmonary-TB
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The progression of tuberculosis is regulated/ Mycobacterium tuberculosis involves both
controlled almost entirely by the cell mediated macrophages and lymphocytes1, the macrophages
immune response (CMI) of the host against the being the major cells involved in the CMI response.
pathogen. - T h e  i m m u n e  r e s p o n s e  a g a i n s t The uptake of pathogens by the macrophages is
Present address : *Malaria Research Centre (ICMR), 2 Nanak Enclave, Radio Colony, Delhi  110009
86
SELVARAJ et al : NON-MHC GENE POLYMORPHISM & LYMPHOCYTE & TUBERCULIN RESPONSE IN PULMONARY TB  87
facilitated by various serum proteins and receptors
of macrophages such as mannose binding protein
(also known as mannose binding lectin), complement
components, mannosyl receptors, complement
receptors and Fc receptor for IgG antibody2,3. Vitamin
D 3  ( 1 , 2 5  d i h y d r o x y  v i t a m i n  D 3 )  i s  a n
immunoregulatory h o r m o n e  a n d  a c t i v a t e s
monocytes /macrophages  and s t imulates  cel l
mediated immunity4. Vitamin D is one of the few
m e d i a t o r s  s h o w n  t o  i m p a i r  t h e  g r o w t h  o f
M. tuberculosis in the macrophages5. The effects of
vitamin D are exerted by the interaction through
vitamin D receptor. It has been suggested that mutant
alleles of the VDR gene region may be associated
w i t h  i n c r e a s e d  o r  d e c r e a s e d  V D R  m R N A
expression6.
Monocytes/macrophages play a major role in the
host defense against M. tuberculosis and secrete
inflammatory cytokines at the site of infection. IL-1
receptor antagonist (IL- 1RA) is one of the cytokines
which competes for the IL-l binding site. IL- la and
IL-1ß exert their effects by interaction with IL-l
receptor and the effect is antagonized by IL-1RA7.
Macrophages from heterozygote carriers of IL-1RA
allele 2 have been shown to produce more IL-1RA
and less IL-la than other genotypes8. MBP, VDR
and IL-IRA genes play a role on macrophage
activation as well as production of cytokine factors.
The cytokines released by the macrophages and
lymphocytes are involved in eliciting a good CMI
response at the site of infection. Our recent study
revealed that functional mutant homozygotes (FMH)
of MBP is associated with the susceptibility to
pulmonary TB9. Further, variant mutant genotype (tt)
of VDR is associated with the susceptibility to
pulmonary TB in female patients10.
Earlier studies revealed that HLA-Class II genes/
gene products are associated with genetically
controlled differences in delayed hypersensitivity
skin responses to M. leprae 11 and M. tuberculosis 12-14.
Since, non-MHC genes/gene products also regulate
the immune function, the goal of the present study
was to find out whether the gene variants of non-
MHC genes such as MBP, VDR, IL- 1RA influence
the lymphocyte response to M. tuberculosis culture
filtrate antigen and tuberculin reactivity status to
purified protein derivative (PPD) of M. tuberculosis
in pulmonary TB patients.
Material & Methods
Study subjects :
(i) Active tuberculosis patients (ATB) – Patients
attending the Tuberculosis Research Centre (TRC),
Chennai, with respiratory symptoms and radiographic
abnormalities suggestive of pulmonary TB were
studied. These patients had sputum positive for
M. tuberculosis by smear and culture. Blood samples
were taken before the start of chemotherapy. A total
of 44 patients aged 37.1 ± 1.7 yr (mean ± SE) were
studied.
(ii) Controls – Control subjects comprised 32
normal healthy subjects (NHS) and 35 family contacts
(CT); spouses of patients of pulmonary TB and TB
spine. Normal healthy subjects were from among
the staff of TRC. The family contacts lived with the
patients before, during and after treatment for a period
of 10-15 yr. All the healthy subjects and the family
contacts (spouses) were clinically normal at the time
of blood sample collection. The patients and spouses
were not consanguineous to each other. The patients
and the controls were randomly selected and matched
for ethnic group. They were Tamil speaking south
I n d i a n  p o p u l a t i o n  ( b e l o n g i n g  t o  d i f f e r e n t
communities/castes) living in and around Chennai,
Tamil Nadu, India. The mean age with SE for the
family contacts was 38.8 ± 2.0 and for the normal
healthy subjects it was 38.5 ± 1.5 yr.
M. tuberculosis culture filtrate antigen : H37Rv strain
of M. tuberculosis  was grown for 6 wk (late
logarithmic phase) as a surface pellicle on Sauton’s
medium at 37°C. The culture was centrifuged at
3,000 rpm for half an hour to remove the bacilli and
the supernatant was filtered through a Seitz filter
(0.45 pm) (Seitz-Filter-Werke GmbH und Co.,
Badkreuznack, Germany) to ensure complete
removal of the bacilli. The culture filtrate antigens
were precipitated with 80 per cent ammonium
sulphate and dissolved in sterile phosphate buffered
saline (PBS; pH 7.4). The excess salt was removed
by dialysis using 0.2 M, 0.1 M and. 0.02 M PBS
(PH 7.4) at 4°C. The dialysed protein was lyophilised
and resuspended in minimal volume of sterile PBS.
The protein concentration was estimated by Lowry’s
procedure15  against bovine serum albumin as
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standard. The culture filtrate protein antigens were
aliquoted and stored at -20°C until required. The
antigen concentration used for lymphocyte response
was 10.0 µg/ml of culture.
Lymphocyte transformation test: Ficoll-Hypaque
separated peripheral blood mononuclear cells
(PBMC) of pulmonary TB patients, patient contacts
and normal healthy subjects (NHS) were suspended
in RPMI tissue culture medium (Sigma Chemical
CO., St. Louis, USA) supplemented with 2mM
L -g lu tamine (Flow Laborator ies , Scotland),
gentamycin  (10 µg/ml;  M.A.  Bio  Products ,
Walkersville, Maryland, USA), fungizone (5 µg/ml;
Squibb, Princeton, NJ, USA) and 10 per cent
autologous plasma for control subjects. Autologous
serum was used instead of plasma in the cultures set
up with samples from pulmonary tuberculosis
patients to avoid clotting in the culture. No difference
was observed in the counts when autologous plasma
or serum was used. 0.1 x 106 PBMC in 200 µl were
cultured with M. tuberculosis culture filtrate antigen
at 10 µg/ml concentration. Cultures without any
stimulation served as controls. Cultures with
M. tuberculosis culture filtrate antigen were kept for
144 h (6 days) in a 96 well ‘U’ bottom tissue culture
plate (Costar, Cambridge, MA, USA), at 37°C and
5 per cent carbon dioxide in a CO2 incubator (Flow
Laboratories Ltd., Rickmansworth, Hertz, UK). The
lymphocyte cultures were set up at least in triplicate.
Tritiated thymidine (3H; BARC, Mumbai, India) was
added to each well (1 µCi/well) 16 h before
termination. The cells were harvested onto glass fibre
filters using a PHD cell harvester (Cambridge
Technology, Inc. Water Town, MA, USA). The
lymphocyte response to M. tuberculosis antigen was
measured by tritium labelled thymidine uptake by
the cells in a scintillation system using a Beta counter
(LKB, Wallac, Oy, Turku, Finland) and expressed as
counts per minute (cpm). The mean cpm value of
the triplicate culture was calculated and the
stimulation index (SI) was derived using the formula:
SI : mean cpm of antigen stimulated cell cultures
mean cpm of cell cultures without antigen
Tuberculin skin test: The results on tuberculin reactive
status of 146 pulmonary TB patients of controlled
clinical trials was analysed retrospectively to find
out whether the gene variants of non-MHC genes
influence the tuberculin status.
DNA extraction: DNA was extracted from the
peripheral blood white cells using salting out
procedure16.
Genotyping of candidate genes: The genotyping of
mannose binding protein (MBP) gene, vitamin D
receptor (VDR) gene and Interleukin-1 receptor
antagonist (IL-IRA) gene of pulmonary tuberculosis
patients has been described elsewhere9,10. The work
on lymphocyte transformation and the genotyping
of MBP and VDR were carried out during 1995 to
1997.
Statistical analysis: Frequencies of the MBP, VDR
and IL-1RA candidate genotypes in the pulmonary
TB patient groups and controls were analysed using
c2 analysis employing the Statcalc program (Epi Info,
Version-5; USD; Stone Mountain, GA, USA). The
results on the lymphocyte response and tuberculin
reactivity are expressed as mean ± standard error
(SE). Statistical significance was assessed using
Kruskal-Wallis one-way analysis of variance by
ranks and in case of a significant result, multiple
comparison test was carried out to identify the pairs
of study groups having significantly different levels
of the parameter.
Results
A significantly decreased lymphocyte response
to M. tuberculosis culture filtrate antigen was seen
in active TB patients positive for functional mutant
homozygotes (FMH) (00) of MBP as compared to
heterozygote carriers (AO) and patients homozygous
for wild type alleles (AA). (MBP: AA vs OO P<0.01;
AO vs OO (P<0.02; Fig. 1). No dramatic difference
in the lymphocyte response to M. tuberculosis
antigen was seen with the vitamin D receptor
genotypes TT (wild type homozygotes) and Tt
(heterozygote carrier) of normal healthy subjects,
contacts and active pulmonary tuberculosis patients.
However, a significantly increased lymphocyte
response was observed in normal healthy subjects
and patient contacts compared to active TB patients
with mutant genotype (tt) of VDR (NHS vs ATB
P<0.02; CT vs ATB P<0.05). No difference in the
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Genotypes
Fig. 1. influence of variant genotypes of MBP, VDR and IL-1RA genes on M. tuberculosis culture filtrate antigen induced lymphocyte response
in active pulmonary TB (ATB) patients, family contacts (CT) and normal healthy subjects (NHS). Results are mean ± SE. Numbers in parantheses
represent the number of subjects studied in each group.
Mannose binding protein (MBP) genes: A, wild type allele; O, mutant alleles of MBP genes 52, 54, 57; AA, wild type homozygotes: AO,
heterozygote carriers; OO, functional mutant homozygotes; ATB *P< 0.01 compared to AA; **P <0.02 compared to AO.
Vitamin-D receptor(VDR) genes: T, wild type allele; t, mutant allele; TT, wild type homozygotes: Tt, heterozygote carrier: tt mutant homozygotes:
tt - †P<0.02: ††P<0.05 compared to ATB.
Interleukin-1 receptor antagonist (IL-1RA) genes: 11, homozygotes for allele 1; 12, heterozygotes for allele 1 & 2; 22, homozygotes for allele 2.
11 - $ P <0.01; $$ P <0.05 compared to ATB. 11 vs 22 - £ P <0.05 compared to NHS and CT of 11 genotypes. Selected genotypes (high frequency)
only studied. Other combinations not determined.
lymphocyte response was observed in active
pulmonary tuberculosis patients with 11, 12 and 22
of IL- 1RA genotypes. However, IL-1RA genotype
11 was significantly associated with increased
lymphocyte response in normal healthy subjects
(P< 0.01) and contacts (P<0.05) when compared to
active TB patients with 11 genotype. Moreover, a
decreased lymphocyte response was observed in
contro l  subjec ts  (NHS & CT)  wi th  IL-1RA
genotype 22 when compared to 11 genotype of
control subjects (P<0.05).
Active tuberculosis patients with the genotype AO
(heterozygote carriers) of MBP showed a significantly
decreased (P<0.001) tuberculin reactivity when
compared to patients with wild type genotype AA
(wild type homozygotes) of MBP However, patients
with the mutant genotype OO (functional mutant
homozygotes) of MBP did not show any marked
increase or decrease in the tuberculin reactivity when
compared to the genotype AA or AO of MBP
(Fig. 2). No difference in the tuberculin reactivity
pattern was seen with variant genotypes of vitamin D
receptor (VDR) and interleukin-1 receptor antagonist
(IL-IRA) genes (Fig.2).
No difference in the tuberculin status was
observed between male (19.5 ± 0.5) and female
(21.5 ± 0.8) patients. However, female pulmonary
TB patients with the vitamin D receptor genotype Tt
(heterozygote carrier) showed a higher tuberculin
reactivity than male pulmonary TB patients with Tt
genotype (P<0.001; Fig. 3). No marked difference
in the tuberculin reactive status was seen between
male and female pulmonary TB patients positive for
either wild type homozygotes (TT) or mutant
homozygotes (tt) of VDR.
Discussion
In active pulmonary tuberculosis, the functional
mutant homozygotes (FMH) of MBP (00) are
associated with a decreased lymphocyte response to
M. tuberculosis  culture filtrate antigen when
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Fig. 2. Influence of variant genotypes of MBP, VDR and IL-1RA
genes on tuberculin reactivity in pulmonary TB patients. Results are
mean ± SE. *P <0.001 compared to AA. Numbers studied in each
group are represented in parentheses.
Mannose binding protein (MBP) genes: A. wild type allele: O,
represents the mutant alleles of MBP genes 52, 54 and 57.
Vitamin-D receptor (VDR) genes: T, wild type allele: t, mutant allele.
Interleukin-1 receptor antagonist (IL-IRA) genes: Selected genotypes




Fig. 3. Influence of vitamin D receptor genotypes on tuberculin
reactivity status in male and female pulmonary TB patients. Results
arc mean ± SE. Numbers studied in each group are represented in
parenthesis. *P <0.001 compared to Tt males.
compared to wild type homozygotes (AA) and
heterozygotes (AO) of MBP in active TB patients.
Due to lack of mutant homozygotes (OO) among
the control subjects (except one normal healthy
subject) such a difference could not be compared
with the controls. Our recent study9 in pulmonary
TB revealed that functional mutant homozygotes as
well as heterozygote carriers of MBP genes are
independently associated with the susceptibility to
pulmonary TB apart from HLA-DR2. Our earlier
studies17,18 also revealed that HLA-DR2 is associated
with susceptibility to pulmonary TB as well as a
decreased spontaneous lymphocyte response. In the
present study also FMH (OO) of MBP was associated
with a decreased antigen induced lymphocyte
response. Though FMH is associated with decreased
lymphocyte response in pulmonary TB, no such
difference was noted in the tuberculin response. The
same mutant allele in combination with wild type
allele (AO; heterozygote carrier) decreases the
tuberculin response to PPD. FMH has been shown
to be associated with low serum level of MBP which
results in recurrent infections19,20. The decreased
lymphocyte response found in the present study may
be due to impaired macrophage function. MBP has
been shown to interact with macrophages through
various receptors. In pulmonary TB, FMH of MBP
may be associated with low level of serum mannose
binding protein which may affect the antigen
(glycoprotein components of M. tuberculosis culture
filtrate antigen) uptake by the macrophages. This in
turn may affect antigen presentation by macrophages
and antigen recognition by lymphocytes which may
lead to decreased lymphocyte response as well as
cytokine response. This may affect the CMI response
in pulmonary TB. This suggests that the mutant allele
either alone or in combination with the wild type
allele may be associated with a decreased CMI
response which may allow M. tuberculosis to establish
the infection in a susceptible host and lead to
progression of the disease.
The mutant genotype tt of VDR was associated
with increased antigen induced lymphocyte response
in normal healthy subjects as well as contacts when
compared to active TB patients. It has been shown
that the mutant VDR genotype tt is associated with
increased VDR expression6. Moreover, the action of
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vitamin D has been shown to be exerted through
VDR6. Vitamin D activates the macrophages and
lymphocytes through vitamin D receptors effectively.
This in turn leads to increased production of various
proteins and cytokines and other factors which may
augment the lymphocyte r e s p o n s e  t o
M. tuberculosis antigen in control subjects. However,
such an increase was not seen in active tuberculosis
patients. This may be due to altered cytokine response
or other factors which could inhibit or alter the
lymphocyte response to M. tuberculosis in the active
stage of tuberculosis. An increased tuberculin
reactivity status was seen. in the vitamin D receptor
genotype Tt of female patients with pulmonary TB.
Tuberculin reactivity status has been correlated to
M. tuberculosis infection. Our earlier study10
suggested that tt  genotype is associated with
susceptibility to pulmonary tuberculosis in female
patients. It has been shown that the allele t plays an
Important role in female subjects. The VDR genotype
tt is associated with bone mineral density as well as
susceptibility to tuberculosis in females21,22. Recent
studies on VDR genotypes and different types of
leprosy23 and HIV infection (Ali et al, personal
communicat ion)  suggest  that  the  VDR gene
polymorphism may be of  immunoregulatory
importance for many diseases. Further studies on the
role of other VDR genes such. as A, a (Apal
polymorphism) and B, b (Bsml polymorphism) will
exp lo re  t he  immune  mechan i sm o f  d i s ea se
susceptibility to tuberculosis.
Though IL-1RA genotype 22 in the control
subjects may be associa ted wi th  decreased
lymphocyte response to M. tuberculosis antigens
when compared to IL-IRA genotype 11, such a
decrease was not observed in the patient group with
22 genotype. On the other hand, an increased antigen
induced lymphocyte response was seen in patients
with 22 genotype when compared to 22 genotype
of control subjects as well as patients with 11
genotype. It has been shown that macrophages with
heterozygote carriers of IL-IRA allele 2 produce
more IL-IRA and less IL-1 a than with other
genotypes8. Further, 22 genotypes have been shown
to be associated with autoimmune diseases24. The
decreased lymphocyte response associated with
IL- 1RA genotype 22 of control subjects may be
associated with increased production of IL- 1RA. In
turn IL- 1RA may affect the IL- 1 interaction with other
cells which may affect the production of other
cytokines such as IL-2 which in turn may affect the
lymphocyte response to M. tuberculosis .  The
increased or decreased lymphocyte response seen
in the patient group may be due to altered level of
cytokines produced by the macrophages and
lymphocytes.
The present study suggests that the non-MHC
genes such as mannose binding protein gene and
vitamin D receptor gene along with other MHC and/
or non-MHC genes (multicandidate genes) may
regulate or control the CMI response in a susceptible
or a resistant host to tuberculosis. Since MBP and
VDR genes are associated with the susceptibility to
tuberculosis, further studies on the level of cytokines
that are associated with the protective immunity may
throw more light on the role of host genetics on the
immune mechanism of susceptibility/resistance to
tuberculosis.
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